DENINTUZUMAB MAFODOTIN
UNII H5324S1M7H

Substance Identification & Data

This profile provides standardized clinical and technical data for Denintuzumab Mafodotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H5324S1M7H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1399672-02-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H5324S1M7H

CAS Registry Number

1399672-02-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DENINTUZUMAB MAFODOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C105150

National Cancer Institute reference terminology for clinical and research data.

INN ID

9886

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-82

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Denintuzumab Mafodotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DENINTUZUMAB MAFODOTIN

Common Names & Synonyms

DENINTUZUMAB MAFODOTIN [INN]

DENINTUZUMAB MAFODOTIN [USAN]

DENINTUZUMAB MAFODOTIN [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HBU12 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HBU12 .KAPPA.-CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-N-METHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL- (.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-L-PHENYLALANINE

IMMUNOGLOBULIN G1-KAPPA AURISTATIN F CONJUGATE, ANTI-(HOMOSAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)), HUMANIZED MONOCLONAL ANTIBODY